Sugi Predict

Sugi Predict / Compounds / SCHEMBL23926476

SCHEMBL23926476

SCHEMBL23926476

O=[N+]([O-])c1cnc2c(ccn2CC(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ DGAT1 O75907 1/20 0.34
▸ MAPT P10636 4/20 0.34
▸ GLS O94925 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ ENPP3 O14638 1/20 0.33
▸ ENPP1 P22413 1/20 0.33
▸ AR P10275 1/20 0.33
▸ POLB P06746 2/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ CXCR5 P32302 1/20 0.33
▸ APLNR P35414 1/20 0.33
▸ CCR6 P51684 1/20 0.33
▸ KAT2B Q92831 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23926506 0.85 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AMAPTGLS
SCHEMBL3649421 0.80 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AMAPTGLS
SCHEMBL15712678 0.78 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AMAPTGLS
SCHEMBL27864136 0.78 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AMAPTENPP3
SCHEMBL27912918 0.77 GLO1 (0.47) ALDH1A1MEN1KMT2AMAPTGLS
SCHEMBL30794117 0.77 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AMAPTMAPK1
SCHEMBL15712849 0.77 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL3653734 0.76 GLO1 (0.48) ALDH1A1MAPTPOLBKAT2B
SCHEMBL18491500 0.76 AR (0.49) GLSARHSP90AA1
SCHEMBL17253109 0.76 DGAT1 (0.37) MEN1KMT2ADGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590071-B2 Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2026-03-31 — — US disclosed
US-20220396553-A1 NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-12-15 — — US disclosed
CN-113727972-A Novel hydrazone derivatives in which terminal amino group is substituted with aryl or heteroaryl group, and use thereof 韩国科学技术研究院 2021-11-30 — — CN disclosed
EP-3901139-A1 NOVEL HYDRAZONE DERIVATIVE WITH ARYL OR HETEROARYL GROUP SUBSTITUTED AT TERMINAL AMINE GROUP THEREOF AND USE THEREOF Korea Institute of Science and Technology (KR) 2021-10-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590071-B2 Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof ABL1, TH, CYP3A43 ALDH1A1 1008/4885MEN1 1574/4885KMT2A 1604/4885
US-20220396553-A1 NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF AANAT, NAT1, HNMT ALDH1A1 402/4885MEN1 1847/4885KMT2A 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.